Genomics|Update|Current: CANCER

Genomics|Update|Current

Cancer

Enabling a genetically informed approach to cancer medicine: A retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel 
Johnson DB, et al. Oncologist 2014 May

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing 
Sharma P, et al. Breast Cancer Res Treat 2014 May

Influence of a genomic classifier on postoperative treatment decisions in high-risk prostate cancer patients: Results from the PRO-ACT study 
Michalopoulos SN, et al. Curr Med Res Opin 2014 May

Patient-reported hereditary breast and ovarian cancer in a primary care practice.
Quillin JM, et al.  J Community Genet. 2014 Apr;5(2):179-83.

Few women at high-risk for hereditary breast and ovarian cancer receive genetic counseling, EurekAlert, May 8

Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing 
Elsayegh N, et al. Ann Surg Oncol 2014 May

Prostate Cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM, et al. Eur Urol. 2014 Jun;65(6):1069-75.

Genetic variants in predicting aggressive prostate cancer: “Ready for prime time?”  
Adriana C. Vidal  et al. European Urology: 01 June 2014

Gene expression analysis for prostate cancer management, Blue Cross Blue Shield Health Technology Assessment Report, May 2014